One reason might be that primers recognizing all GAS5 ESTs were used in the breast cancer study [41], while in our case primers were recognizing only 20 out of 29 different splice variants, which nevertheless included the splice variants detected in cancer cells. This evidence concerns the gene GAS5 and breast carcinoma.